Jellatech CEO Stephanie Michelsen said: “Our new facility represents a leap forward in our ability to deliver high-quality, consistent and ethically produced proteins for human health and longevity applications. This move not only significantly increases our production capacity but also reinforces our commitment to setting new standards in sustainability, innovation and cutting edge biotechnology.”
Source: Jellatech opens new 9,000-square-foot US facility | The Cell Base